8 min. read

RCT shows no effect for AI coach. Livongo ups enrollment rate.

Issue 042. Get E&O weekly. | Subscribe

Digital health research from Brian Dolan.

Welcome to E&O.

Last week's newsletter had a 59 percent open rate. Here's what's happening this week:

  • HIMSS 2020, the biggest annual conference focused on health IT, is canceled because of the COVID-19 pandemic. HIMSS bought my first company, MobiHealthNews, and I still know a lot of the people there. They made the right call, but I do worry about how this impacts the future of the organization. (The big event drives almost everything at HIMSS.) Here's hoping for the best.
  • Besides the above, going to try to avoid writing about COVID-19 for now. Safe to assume you all are already overwhelmed. (Apologies in advance for this week's bubonic plague doctor GIF below.)
  • Voluntis announced another oncology DTx deal, this time with Bristol-Myers Squibb. It also announced plans to dial back its diabetes business in

Paying Subscribers Only

It's a good one, too.
This digital health research is for paying Exits & Outcomes subscribers only. Subscribe now to read this article, get the weekly newsletter, and receive unrestricted access to past and future research from the Exits & Outcomes archives. Smash the link above or below to subscribe yourself -- or head over to our pricing page to subscribe your team or your whole company!

Recent Articles